as on November 28, 2025 at 11:29 pm IST
Day's Low
Day's High
7.77%
Downside
2.18%
Upside
52 Week's Low
52 Week's High
72.09%
Downside
202.43%
Upside
Check Minerva Neurosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$26.9M
EPS (TTM)
-1.4
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-14.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-675.09%
Compare market cap, revenue, PE, and other key metrics of Minerva Neurosciences, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $26.9M | -88.22% | NA | 0.00% | ||
| BUY | $43.6B | 413.84% | -16.34 | -264.83% | |
| BUY | $58.8B | 242.77% | 1435.87 | 1.36% | |
| BUY | $110.8B | 90.63% | 30.22 | 31.35% | |
| BUY | $83.2B | 52.63% | 18.87 | 32.13% |
The Minerva Neurosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Minerva Neurosciences, Inc. investment value today
Current value as on today
₹1,97,504
Returns
₹97,504
(+97.5%)
Returns from Minerva Neurosciences, Inc. Stock
₹91,628 (+91.63%)
Dollar Returns*
₹5,876 (+5.88%)
Based on 6 analysts
0.00%
Buy
50.00%
Hold
50.00%
Sell
Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Minerva Neurosciences, Inc.. Average target price of $4
Get share price movements and forecasts by analysts on Minerva Neurosciences, Inc..
What analysts predicted
-3%DOWNSIDE
Target Price
$4
Current Price
$4.12
Analyzed by
6 Analysts
Target
$4.00
Minerva Neurosciences, Inc. target price $4, a slight downside of -3% compared to current price of $4.12. According to 6 analysts rating.
Search interest for Minerva Neurosciences, Inc. Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 21 October
Tue, 06:40 PM
-Minerva Neurosciences announces $200 million funding for roluperidone development, including $80 million upfront for Phase 3 trial.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1006.1% return, outperforming this stock by 992.2%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 169.5% return, outperforming this stock by 93.7%
Price Dip
![]()
In the last 7 days, NERV stock has moved down by -4.1%
| Organisation | Minerva Neurosciences, Inc. |
| Headquarters | 1500 District Avenue, Burlington, MA, United States, 01803 |
| Industry | Health Technology |
| CEO | Dr. Remy Luthringer Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Remy Luthringer Ph.D. | Executive Chairman & CEO |
Mr. Geoffrey Robin Race F.C.M.A., M.B.A. | President |
Mr. Frederick W. Ahlholm CPA | Senior VP, CFO & Secretary |
Mr. Joseph Reilly | Senior VP & COO |
Mr. William B. Boni | Vice President of Investor Relations & Corporate Communications |
Prof. Michael Davidson M.D. | Chief Medical Officer |
Minerva Neurosciences, Inc. share price today is $4.12 as on at the close of the market. Minerva Neurosciences, Inc. share today touched a day high of $4.21 and a low of $3.8.
Minerva Neurosciences, Inc. share touched a 52 week high of $12.46 on and a 52 week low of $1.15 on . Minerva Neurosciences, Inc. stock price today i.e. is closed at $4.12,which is 66.93% down from its 52 week high and 258.26% up from its 52 week low.
Minerva Neurosciences, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Minerva Neurosciences, Inc. (NERV) shares with as little as ₹89.436 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹894.36 in Minerva Neurosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Minerva Neurosciences, Inc. share’s latest price of $4.12 as on November 28, 2025 at 11:29 pm IST, you will get 2.4272 shares of Minerva Neurosciences, Inc.. Learn more about
fractional shares .
Minerva Neurosciences, Inc. stock has given -88.22% share price returns and 20.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?